Ozomet-PG 1 Tablet

Ozomet-PG 1 Tablet – For Type 2 Diabetes Management

What is Ozomet-PG 1 Tablet?

Ozomet-PG 1 Tablet is a combination antidiabetic medicine used with diet and exercise to control high blood sugar in adults with Type 2 Diabetes Mellitus. It contains three active ingredients—Glimepiride, Metformin, and Pioglitazone—that work together to improve insulin sensitivity and lower blood glucose levels.

Key Benefits:

✔ Controls blood sugar by improving insulin response
✔ Reduces glucose production in the liver
✔ Helps prevent diabetes complications (kidney damage, nerve problems, vision loss)
✔ Enhances long-term diabetes management when combined with a healthy lifestyle

How to Take Ozomet-PG 1 Tablet:

• Take with food to avoid stomach upset.

• Swallow whole—do not crush, chew, or break.

• Do not skip doses—if missed, take as soon as remembered (unless close to the next dose).

• Avoid alcohol—increases the risk of side effects like hypoglycemia (low blood sugar).

Possible Side Effects:

Most side effects are mild and may include:

• Hypoglycemia (low blood sugar) – dizziness, sweating, weakness

• Nausea, diarrhea, stomach pain

• Headache, dizziness

• Mild anemia or respiratory infections

If symptoms persist or worsen, consult your doctor.

Important Safety Information:

⚠ Alcohol: Unsafe—increases hypoglycemia risk.
⚠ Pregnancy/Breastfeeding: Not recommended—consult your doctor.
⚠ Kidney/Liver Disease: Use with caution—dose adjustments may be needed.
⚠ Driving: Be cautious—low or high blood sugar can affect alertness.

How It Works:

• Glimepiride → Stimulates insulin release from the pancreas.

• Metformin → Reduces liver glucose production & improves insulin sensitivity.

• Pioglitazone → Enhances insulin action in muscles & fat tissues.

Lifestyle Tips for Better Diabetes Control:

• Follow a balanced, low-sugar diet.

• Engage in regular exercise.

• Monitor blood sugar levels frequently.

• Avoid smoking & excessive alcohol.

Always take as prescribed and consult your doctor before making any changes.